EPHB3
Ephrin type-B receptor 3
Also known as: EPHB3_HUMAN, ETK2, Hek2, Tyro6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54753
- Gene
- EPHB3
- Ensembl
- ENSG00000182580
- Chromosome
- 3
- Canonical length
- 998 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted membrane proteins
OverviewNCBI Gene
Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into two groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. This gene encodes a receptor for ephrin-B family members. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
998 residues, UniProt reviewed canonical sequence.
>P54753|EPHB3
1 MARARPPPPP SPPPGLLPLL PPLLLLPLLL LPAGCRALEE TLMDTKWVTS ELAWTSHPES
61 GWEEVSGYDE AMNPIRTYQV CNVRESSQNN WLRTGFIWRR DVQRVYVELK FTVRDCNSIP
121 NIPGSCKETF NLFYYEADSD VASASSPFWM ENPYVKVDTI APDESFSRLD AGRVNTKVRS
181 FGPLSKAGFY LAFQDQGACM SLISVRAFYK KCASTTAGFA LFPETLTGAE PTSLVIAPGT
241 CIPNAVEVSV PLKLYCNGDG EWMVPVGACT CATGHEPAAK ESQCRPCPPG SYKAKQGEGP
301 CLPCPPNSRT TSPAASICTC HNNFYRADSD SADSACTTVP SPPRGVISNV NETSLILEWS
361 EPRDLGGRDD LLYNVICKKC HGAGGASACS RCDDNVEFVP RQLGLTERRV HISHLLAHTR
421 YTFEVQAVNG VSGKSPLPPR YAAVNITTNQ AAPSEVPTLR LHSSSGSSLT LSWAPPERPN
481 GVILDYEMKY FEKSEGIAST VTSQMNSVQL DGLRPDARYV VQVRARTVAG YGQYSRPAEF
541 ETTSERGSGA QQLQEQLPLI VGSATAGLVF VVAVVVIAIV CLRKQRHGSD SEYTEKLQQY
601 IAPGMKVYID PFTYEDPNEA VREFAKEIDV SCVKIEEVIG AGEFGEVCRG RLKQPGRREV
661 FVAIKTLKVG YTERQRRDFL SEASIMGQFD HPNIIRLEGV VTKSRPVMIL TEFMENCALD
721 SFLRLNDGQF TVIQLVGMLR GIAAGMKYLS EMNYVHRDLA ARNILVNSNL VCKVSDFGLS
781 RFLEDDPSDP TYTSSLGGKI PIRWTAPEAI AYRKFTSASD VWSYGIVMWE VMSYGERPYW
841 DMSNQDVINA VEQDYRLPPP MDCPTALHQL MLDCWVRDRN LRPKFSQIVN TLDKLIRNAA
901 SLKVIASAQS GMSQPLLDRT VPDYTTFTTV GDWLDAIKMG RYKESFVSAG FASFDLVAQM
961 TAEDLLRIGV TLAGHQKKIL SSIQDMRLQM NQTLPVQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- skin: 50 nTPM
- salivary gland: 30 nTPM
- esophagus: 30 nTPM
- stomach: 22 nTPM
- cervix: 22 nTPM
- vagina: 20 nTPM
Single-cell type
- esophageal apical cells: 137 nCPM
- mucous neck cells: 107 nCPM
- paneth cells: 93 nCPM
- ocular epithelial cells: 81 nCPM
- parietal cells: 78 nCPM
- enteric stem cells: 76 nCPM
Immune cell
- myeloid DC: 0.7 nTPM
- classical monocyte: 0.2 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 14 nTPM
- cerebellum: 13 nTPM
- cerebral cortex: 9.6 nTPM
- medulla oblongata: 9.6 nTPM
- thalamus: 9.5 nTPM
- midbrain: 8.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 2.73
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- axon guidance
- axonal fasciculation
- cell migration
- central nervous system projection neuron axonogenesis
- corpus callosum development
- dendritic spine development
- dendritic spine morphogenesis
- digestive tract morphogenesis
- ephrin receptor signaling pathway
- positive regulation of synapse assembly
- regulation of axonogenesis
- regulation of cell-cell adhesion
- retinal ganglion cell axon guidance
- roof of mouth development
- substrate adhesion-dependent cell spreading
- thymus development
- urogenital system development
Molecular functions
- ATP binding
- axon guidance receptor activity
- ephrin receptor activity
- transmembrane-ephrin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Tyrosine-protein kinase, active site
- Galactose-binding-like domain superfamily
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- SAM domain (Sterile alpha motif)
- Ephrin receptor ligand binding domain
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
- Ephrin type-B receptor 3, ligand binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHB3 as an antibody target. Whether an autoantibody or antibody against EPHB3 could matter depends on whether native EPHB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHB3 is annotated at the cell surface, where native EPHB3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EPHB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...